Royal Bank of Canada’s Biomerica BMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7
Closed 6865
2024
Q2
$0 Hold
7
﹤0.01% 7065
2024
Q1
$0 Hold
7
﹤0.01% 7024
2023
Q4
$0 Sell
7
-18
-72% -$136 ﹤0.01% 7123
2023
Q3
$0 Sell
25
-28
-53% -$277 ﹤0.01% 7089
2023
Q2
$1K Buy
+53
New +$628 ﹤0.01% 6964
2022
Q4
Sell
-1
Closed 7229
2022
Q3
$0 Buy
+1
New +$26 ﹤0.01% 7448
2021
Q1
Sell
-3
Closed 7425
2020
Q4
$0 Buy
+3
New +$150 ﹤0.01% 7062
2020
Q3
Sell
-181
Closed -$11K 6623
2020
Q2
$11K Buy
+181
New +$10.1K ﹤0.01% 5795
2020
Q1
Sell
-6
Closed 6675
2019
Q4
$0 Buy
6
+4
+200% +$96 ﹤0.01% 6823
2019
Q3
$0 Hold
2
﹤0.01% 6703
2019
Q2
$0 Hold
2
﹤0.01% 6870
2019
Q1
$0 Hold
2
﹤0.01% 6801
2018
Q4
$0 Hold
2
﹤0.01% 6748
2018
Q3
$0 Buy
+2
New +$60 ﹤0.01% 6718

Other funds holding BMRA

Royal Bank of Canada's BMRA Position: Q3 2024 in Review

Royal Bank of Canada sold out of Biomerica (BMRA) in Q3 2024, closing a stake of 7 shares.

Royal Bank of Canada first reported a position in BMRA in Q3 2018 and held it in 14 quarters. The position peaked at $11K in Q2 2020. 25 funds tracked by Wall St. Rank hold BMRA as of Q3 2024.

  • Royal Bank of Canada reported no remaining Biomerica position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 7 Biomerica shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Biomerica in Q3 2018 and held it in 14 quarters.
  • Royal Bank of Canada's Biomerica position peaked at $11K in Q2 2020.
  • 25 funds tracked by Wall St. Rank held Biomerica as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.